Comparison of DNA ploidy, histologic, and immunohistochemical findings with clinical outcome in inflammatory myofibroblastic tumors

Keyphrases

• Clinical Outcomes 100%
• Pathological Findings 100%
• Inflammatory Myofibroblastic Tumor 100%
• DNA Ploidy 100%
• Immunohistochemical Findings 100%
• Malignant Transformation 80%
• Cellularity 30%
• Inflammatory Infiltrate 30%
• Mitosis 30%
• Ganglion-like Cells 30%
• C-Myc 20%
• Recurring 20%
• Older Adults 10%
• Tumor 10%
• B-cell Lymphoma 2 (Bcl-2) 10%
• Bcl-2 Expression 10%
• Histopathological Features 10%
• P53 Expression 10%
• Soft Tissue 10%
• Immunohistochemical Analysis 10%
• Clinical Course 10%
• Flow Cytometric 10%
• Clinical Outcome Prediction 10%
• Regulatory Proteins 10%
• Aggressive Behavior 10%
• Atypia 10%
• Formalin-fixed Paraffin-embedded Tissue 10%
• DNA Expression 10%
• Oncogenic Proteins 10%
• Viscera 10%
• DNA Ploidy Analysis 10%
• Cytological Atypia 10%
• P53 DNA 10%
• MYC Expression 10%
• Cellular Atypia 10%
• Spindle Cell Proliferation 10%
• Rare Example 10%
• Behavior Transformation 10%

Medicine and Dentistry

• Plasma Cell Granuloma 100%
• Ploidy 100%
• Malignant Transformation 80%
• Recurrent Disease 50%
• Protein P53 30%
• Inflammatory Infiltrate 30%
• Ganglion 30%
• Oncogene C Myc 30%
• Cell Proliferation 10%
• Morphology 10%
• Carcinogenesis 10%
• Biological Product 10%
• Tumor 10%
• Disease Course 10%
• Spindle Cell 10%
• Aneuploidy 10%
• Viscera 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Plasma Cell Granuloma 100%
• Malignant Transformation 80%
• Recurrent Disease 50%
• Protein P53 30%
• Inflammatory Infiltrate 30%
• Carcinogenesis 10%
• Biological Product 10%
• Disease Course 10%
• Aneuploidy 10%